Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models

被引：0
|
作者：
Kaori Fujimoto-Ouchi
Fumiko Sekiguchi
Hideyuki Yasuno
Yoichiro Moriya
Kazushige Mori
Yutaka Tanaka
机构：
[1] Chugai Pharmaceuticals Co.,Product Research Department, Kamakura Research Center
[2] Ltd,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2007年 / 59卷
关键词：
Trastuzumab; Antitumor activity; Human xenograft models; Gastric cancer; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：795 / 805
页数：10
相关论文
共 50 条
  • [21] PRECLINICAL ANTITUMOR ACTIVITY OF THIARABINE IN HUMAN LEUKEMIA AND LYMPHOMA XENOGRAFT MODELS
    Waud, William R.
    Gilbert, Karen S.
    Secrist, John A., III
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2012, 31 (09): : 647 - 660
  • [22] Antitumor activity of the Aurora A inhibitor MLN8237 in combination with Docetaxel in xenograft models of breast and prostate cancer
    Huck, Jessica
    Zhang, Mengkun
    Hyer, Marc
    Yu, Li
    Stringer, Bradley
    Yang, Yu
    Ecsedy, Jeffrey
    Manfredi, Mark
    CANCER RESEARCH, 2009, 69
  • [23] Chemotherapy-free, triple combination of obinutuzumab, venetoclax and idasanutlin: antitumor activity in xenograft models of non-Hodgkin lymphoma
    Herting, Frank
    Friess, Thomas
    Umana, Pablo
    Middleton, Steven
    Klein, Christian
    LEUKEMIA & LYMPHOMA, 2018, 59 (06) : 1482 - 1485
  • [24] Biomarkers for antitumor activity of bevacizumab in gastric cancer models
    Yamashita-Kashima, Yoriko
    Fujimoto-Ouchi, Kaori
    Yorozu, Keigo
    Kurasawa, Mitsue
    Yanagisawa, Mieko
    Yasuno, Hideyuki
    Mori, Kazushige
    BMC CANCER, 2012, 12
  • [25] Biomarkers for antitumor activity of bevacizumab in gastric cancer models
    Yoriko Yamashita-Kashima
    Kaori Fujimoto-Ouchi
    Keigo Yorozu
    Mitsue Kurasawa
    Mieko Yanagisawa
    Hideyuki Yasuno
    Kazushige Mori
    BMC Cancer, 12
  • [26] Enhanced antitumor activity of irofulven in combination with irinotecan in pediatric solid tumor xenograft models
    Michael H. Woo
    Jennifer K. Peterson
    Catherine Billups
    Hua Liang
    Mary-Ann Bjornsti
    Peter J. Houghton
    Cancer Chemotherapy and Pharmacology, 2005, 55 : 411 - 419
  • [27] Enhanced antitumor activity of irofulven in combination with irinotecan in pediatric solid tumor xenograft models
    Woo, MH
    Peterson, JK
    Billups, C
    Liang, H
    Bjornsti, MA
    Houghton, PJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 55 (05) : 411 - 419
  • [28] Enhanced antitumor effects of oncolytic reovirus and trastuzumab combination therapy in human HER2-positive gastric cancer
    Kataoka, H.
    Hamano, S.
    Aoyama, M.
    Mori, Y.
    Tanaka, M.
    Hayashi, N.
    Kubota, E.
    Johnston, R.
    Joh, T.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S183 - S183
  • [29] The Synergistic Antitumor Activity of Chidamide in Combination with Bortezomib on Gastric Cancer
    Zhang, Wanjun
    Niu, Junwei
    Ma, Yongcheng
    Yang, Xiawan
    Cao, Huixia
    Guo, Honggang
    Bao, Fengchang
    Haw, Ahmed
    Chen, Yuqing
    Sun, Kai
    ONCOTARGETS AND THERAPY, 2020, 13 : 3823 - 3837
  • [30] ANTITUMOR ACTIVITY OF BEVACIZUMAB IN COMBINATION WITH ERLOTINIB IN HUMAN NON-SMALL CELL LUNG CANCER XENOGRAFT MODEL
    Li, Heyan
    Takayama, Koichi
    Shiraishi, Yoshimasa
    Wang, Shuo
    Furuyama, Kazuto
    Harada, Taishi
    Nakanishi, Yoichi
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S462 - S462
12345